一、中文名称：Research Grade Onercept (DHB94438)，研究级Onercept类似物,奥那西普
二、产品描述
Onercept 是一种重组的可溶性人肿瘤坏死因子-αp55 受体，可用于克罗恩病研究。
三、产品详情
名称：Research Grade Onercept (DHB94438)
别名：Onercept (USAN/INN), r-hTBP, R-HTBP-1, R-TBP-1, rTBP-1, TBP, TBP 1, TBP I, TNF-BP1, Tumour necrosis factor binding protein 1
货号：DHB94438
表达系统：Mammalian Cells
种属反应性：Human
同种型：Glycoprotein TNF-bp (Tumor necrosis factor-binding protein, TBP1)
克隆类型：Monoclonal
靶标：TNF, Tumor necrosis factor ligand superfamily member 2, N-terminal fragment, ICD2, NTF, TNF-a, TNF-alpha, Tumor necrosis factor, TNFSF2, TNFA, Cachectin, ICD1
浓度：1 mg/ml
内毒素水平：Please contact with the lab for this information.
纯度：>95% as determined by SDS-PAGE.
纯化方式：Protein A/G purified from cell culture supernatant.
Accession号：P01375
克隆号：Onercept
应用：Research Grade Biosimilar
状态：Liquid
保存溶液：0.01M PBS, pH 7.4.
稳定性和存储：Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
四、参考文献：
Mechanism of Action of Anti-TNF Therapy in Inflammatory Bowel Disease.PMID:26896086
Clinical development of onercept, a tumor necrosis factor binding protein, in psoriasis.PMID:20718590
Onercept. Serono.PMID:14758777
Onercept for moderate-to-severe Crohn's disease: a randomized, double-blind, placebo-controlled trial.PMID:16797249
Psoriatic arthritis.PMID:15379770
New biologic therapeutics for ulcerative colitis and Crohn's disease.PMID:24502344
Population pharmacokinetics of onercept in healthy subjects.PMID:16372827
Gateways to clinical trials.PMID:12743628
Treatment of active Crohn's disease with onercept (recombinant human soluble p55 tumour necrosis factor receptor): results of a randomized, open-label, pilot study.PMID:12534402
Anti-TNF therapy in Crohn's disease.PMID:15669643
详情请咨询Antibodysystem中国授权总代理-武汉佰乐博生物技术有限公司
网址：https://www.antibodysystem.com/product/23183.html
武汉佰乐博生物技术有限公司作为法国Antibodysystem品牌亚洲区授权总代理。提供近3万种蛋白、抗体等核心生命科学试剂，旨在为生命科学科研工作者提供专业、全面、可靠的试剂产品。
试剂 | 耗材 | 定制 | 实验服务 | 供应链
免费热线：027-65279366 /18108604356
